Estonia vs Monaco: Life science patents granted, by technology

Estonia
1 patents
in 2018
Monaco
1 patents
in 2020
Estonia rank
54th
Monaco rank
54th

Life science patents granted, by technology over time

  • Estonia
  • Monaco
020406080198020002020

How they compare

Estonia currently reports 1 patents against 1 patents in Monaco, a difference of 0 patents.

The two have swapped places 1 time across 11 shared years of data; in 1996 it was Estonia ahead.

Estonia ranks 54th and Monaco ranks 54th of 64 countries.

Estonia has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Estonia Monaco Difference Ahead
1990s 13.5 patents 2 patents 11.5 patents Estonia
2000s 46.8 patents 1.6 patents 45.2 patents Estonia
2010s 13.25 patents 1.25 patents 12 patents Estonia

Averages of every year both report within each decade.

Frequently asked questions

Which has higher life science patents granted, by technology, Estonia or Monaco?
Estonia, at 1 patents against 1 patents in Monaco as of 2018.
What is the difference in life science patents granted, by technology between Estonia and Monaco?
0 patents, with Estonia ahead.
How many years of comparable data are there for Estonia and Monaco?
11 years are reported by both, from 1996 to 2017.
How do Estonia and Monaco rank globally for life science patents granted, by technology?
Estonia ranks 54th and Monaco ranks 54th of 64 countries.
Where does this data come from?
World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data, published as Life science patents granted, by technology. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator
Life science patents granted, by technology
Unit
patents
Source
World Intellectual Property Organization (WIPO) (2025) – processed by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
65 places, 2,044 data points, 1980–2023
Last refreshed

Number of pharmaceutical patents granted by the filing office in a given year. Pharmaceutical patents typically cover new drugs, biological treatments or vaccines.